VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,412,335 | -37.2% | 257,453 | +64.5% | 0.00% | -33.3% |
Q2 2023 | $3,838,406 | -44.9% | 156,478 | -47.7% | 0.00% | -40.0% |
Q1 2023 | $6,959,987 | +8.9% | 299,097 | +18.5% | 0.01% | -16.7% |
Q4 2022 | $6,389,788 | +4.0% | 252,461 | -20.8% | 0.01% | +50.0% |
Q3 2022 | $6,146,000 | +8.9% | 318,780 | +43.8% | 0.00% | 0.0% |
Q2 2022 | $5,646,000 | +370.1% | 221,650 | +374.9% | 0.00% | +300.0% |
Q1 2022 | $1,201,000 | -74.7% | 46,670 | -58.8% | 0.00% | -66.7% |
Q4 2021 | $4,742,000 | -1.7% | 113,262 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $4,823,000 | -1.4% | 110,814 | +7.1% | 0.00% | 0.0% |
Q2 2021 | $4,893,000 | +0.3% | 103,489 | +8.7% | 0.00% | 0.0% |
Q1 2021 | $4,880,000 | +754.6% | 95,191 | +346.4% | 0.00% | – |
Q4 2020 | $571,000 | +173.2% | 21,322 | +249.1% | 0.00% | – |
Q3 2020 | $209,000 | -53.2% | 6,107 | -44.0% | 0.00% | – |
Q2 2020 | $447,000 | +391.2% | 10,907 | +312.4% | 0.00% | – |
Q1 2020 | $91,000 | +405.6% | 2,645 | +83.0% | 0.00% | – |
Q4 2019 | $18,000 | – | 1,445 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |